Do you have the same question? Follow this Question
Nov 14, 2024 - 01:38 PM
We’ve provided several answers to questions related to Rexulti (Brexpiprazole) , see some other helpful Q&A related to this product.
Question: What is the recommended dose for pediatric patients with schizophrenia?
Answer: The recommended dose for pediatric patients with schizophrenia is 2 to 4 mg/day. This dosage range allows for adjustment to achieve the best balance between symptom control and minimizing side effects.
Question: What is the recommended dose for adults with schizophrenia?
Answer: The recommended dose for adults with schizophrenia is 2 to 4 mg/day. This range provides flexibility to adjust the dose based on individual response and symptom control.
Question: What are the routes of administration for this medication?
Answer: The medication is administered by mouth. Oral administration is often convenient and preferred by many patients due to ease of use and non-invasiveness.
Question: What is the elimination half-life of this medication?
Answer: The elimination half-life of this medication is 91 hours. A longer half-life can mean less frequent dosing, which may improve adherence to the medication regimen.
Question: What strengths are available for the tablets?
Answer: The tablets are available in strengths of 0.25 mg, 0.5 mg, 1 mg, 2 mg, 3 mg, and 4 mg. Having multiple strengths allows for tailored dosing to meet individual needs and achieve the best therapeutic outcomes.
